Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 85Unknown 32Recruiting 30Terminated 14Active not recruiting 6Withdrawn 5Not yet recruiting 5Suspended 1No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 33Neoplasms 28Colorectal Neoplasms 19Prostatic Neoplasms 17Lung Neoplasms 13Leukemia, Myeloid, Acute 12Glioblastoma 12Stomach Neoplasms 10Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Melanoma 8Glioma 8Brain Neoplasms 8Rectal Neoplasms 7Ovarian Neoplasms 7Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Hematologic Neoplasms 6Uterine Cervical Neoplasms 5Polycystic Ovary Syndrome 5Multiple Myeloma 5Esophageal Neoplasms 5Carcinoma, Renal Cell 5Triple Negative Breast Neoplasms 4Sarcoma 4Myelodysplastic Syndromes 4Lymphoma, B-Cell 4Lymphoma 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × OTHER × Gastrointestinal Stromal Tumors × Clear all
NCT02924714 2022-02-18

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

Oslo University Hospital

Phase NA Suspended
31 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡